Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma

Clinical Trial ID NCT00068302

PubWeight™ 2.86‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00068302

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies. Br J Haematol 2009 1.25
2 Targeted drug discovery for pediatric leukemia. Front Oncol 2013 0.82
3 Advances in paediatric cancer treatment. Transl Pediatr 2014 0.76
Next 100